Skip to content
Disclosery

Adamant Biomedical Investments AG: BIIB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Adamant Biomedical Investments AG on BIIB, newest first. How the timeline and the estimate are built.

Adamant Biomedical Investments AG held 53,250 BIIB shares at 2014-12-31 per its 13F-HR filed 2015-02-13.

the latest 13F is the newest step

  1. period ended2014-12-31
    13F 53,250 shares
    Change vs previous 13F -1,770 shares

    4.32% of the 13F portfolio, value $18,076,000.

    13F-HR 0000950123-15-002090 filed by Adamant Biomedical Investments AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2014-09-30
    13F 55,020 shares
    Change vs previous 13F not available

    4.54% of the 13F portfolio, value $18,201,000.

    13F-HR 0000950123-14-012192 filed by Adamant Biomedical Investments AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).